| Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia RA Fielding, B Vellas, WJ Evans, S Bhasin, JE Morley, AB Newman, ... Journal of the American Medical Directors Association 12 (4), 249-256, 2011 | 3826 | 2011 |
| Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force GA Van Kan, Y Rolland, S Andrieu, J Bauer, O Beauchet, M Bonnefoy, ... The Journal of Nutrition, Health and Aging 13 (10), 881-889, 2009 | 2381 | 2009 |
| Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 1996 | 2016 |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1930 | 2016 |
| Cognitive frailty: rational and definition from an (IANA/IAGG) international consensus group E Kelaiditi, M Cesari, M Canevelli, GA Van Kan, PJ Ousset, ... The Journal of nutrition, health and aging 17 (9), 726-734, 2013 | 1054 | 2013 |
| Exercise program for nursing home residents with Alzheimer's disease: A 1‐year randomized, controlled trial Y Rolland, F Pillard, A Klapouszczak, E Reynish, D Thomas, S Andrieu, ... Journal of the American Geriatrics Society 55 (2), 158-165, 2007 | 1001 | 2007 |
| Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints … S Andrieu, S Guyonnet, N Coley, C Cantet, M Bonnefoy, S Bordes, ... The Lancet Neurology 16 (5), 377-389, 2017 | 833 | 2017 |
| Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype L Vermunt, SAM Sikkes, A Van Den Hout, R Handels, I Bos, ... Alzheimer's & Dementia 15 (7), 888-898, 2019 | 527 | 2019 |
| Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial B Vellas, N Coley, PJ Ousset, G Berrut, JF Dartigues, B Dubois, ... The Lancet Neurology 11 (10), 851-859, 2012 | 480 | 2012 |
| Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials JT Yu, W Xu, CC Tan, S Andrieu, J Suckling, E Evangelou, A Pan, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (11), 1201-1209, 2020 | 473 | 2020 |
| Advances in the prevention of Alzheimer's disease and dementia A Solomon, F Mangialasche, E Richard, S Andrieu, DA Bennett, ... Journal of internal medicine 275 (3), 229-250, 2014 | 440 | 2014 |
| World‐Wide FINGERS Network: a global approach to risk reduction and prevention of dementia M Kivipelto, F Mangialasche, HM Snyder, R Allegri, S Andrieu, H Arai, ... Alzheimer's & dementia 16 (7), 1078-1094, 2020 | 417 | 2020 |
| IANA task force on nutrition and cognitive decline with aging S Gillette-Guyonnet, GA Van Kan, S Andrieu, P Barberger-Gateau, C Berr, ... Journal of Nutrition Health and Aging 11 (2), 132, 2007 | 385 | 2007 |
| Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study) F Nourhashémi, S Andrieu, S Gillette-Guyonnet, B Vellas, JL Albarede, ... The Journals of Gerontology Series A: Biological Sciences and Medical …, 2001 | 375 | 2001 |
| Beyond the global score of the Zarit Burden Interview: useful dimensions for clinicians J Ankri, S Andrieu, B Beaufils, A Grand, JC Henrard International journal of geriatric psychiatry 20 (3), 254-260, 2005 | 355 | 2005 |
| Weight loss in Alzheimer disease S Gillette-Guyonnet, F Nourhashémi, S Andrieu, I de Glisezinski, ... The American journal of clinical nutrition 71 (2), 637S-642S, 2000 | 348 | 2000 |
| Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions S Andrieu, N Coley, S Lovestone, PS Aisen, B Vellas The Lancet Neurology 14 (9), 926-944, 2015 | 332 | 2015 |
| MAPT study: a multidomain approach for preventing Alzheimer’s disease: design and baseline data B Vellas, I Carrie, S Gillette-Guyonnet, J Touchon, T Dantoine, ... The journal of prevention of Alzheimer's disease 1 (1), 13, 2014 | 309 | 2014 |
| Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with … L Rouch, P Cestac, O Hanon, C Cool, C Helmer, B Bouhanick, ... CNS drugs 29, 113-130, 2015 | 306 | 2015 |
| International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes D Tolson, Y Rolland, S Andrieu, JP Aquino, J Beard, A Benetos, G Berrut, ... Journal of the American Medical Directors Association 12 (3), 184-189, 2011 | 301 | 2011 |
